Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Bioniche Life Sciences’ Vaccine Manufacturing Facility, Belleville, Ontario

Launched

29 April 2011

Investment

$25m

Area

12,000ft² (production); 17,000ft² (utility space)

Production

Vaccines for disease prevention in animals

Owner

Bioniche Life Sciences

General Contractor

Cornerstone Builders

Design Services

Laporte Consultants

Financiers

Ontario Ministry of Economic Development & Trade, Agriculture & Agri-Food Canada Business Development Bank of Canada and the Industrial Technologies Office of Industry Canada
Expand

Free download worth over $5000
Download our 2019 Technology, Media and Telecoms Predictions Report

Worth up to $5,850

In this report, we look at the 30 big tech themes for 2019, identifying winners and losers for each theme. This report will impact all industries helping:

  • CEOs/Senior Staff: in all industries understand the disruptive threats to their competitive landscape
  • Investors: Helps fund managers focus their time on the most interesting investment opportunities in global TM
Close
Close
Close

Go Top